The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Case Vignettes in Metastatic Breast Cancer

A CME-Certified Activity
Published Online:2:16 PM, Thu June 18, 2015

Activity Overview

This activity is designed to educate medical oncologists, surgical oncologists, radiation oncologists, oncology nurses, and other allied health professionals on the optimal management of metastatic breast cancer.

This case-based program is designed to educate these healthcare providers on the optimal management of patients with ER+/HER2– MBC, with the goal of improving patient outcomes including quality of life and survival.

To view this CME activity, click here >>>

Educational Objectives

Upon completing this activity as designed, participants should be able to:

  • Review clinical trial data on current and emerging treatments for patients with ER-positive/HER2-negative MBC
  • Evaluate efficacy and safety data on currently available chemotherapeutic agents for patients with ER-positive/HER2-negative MBC
  • Describe optimal management strategies recommended by evidence-based guidelines for the treatment of patients with ER-positive/HER2- negative MBC
  • Develop individualized treatment plans with consideration for key patient and clinical factors for patients with ER-positive/HER2-negative MBC

Target Audience: Medical oncologists, surgical oncologists, radiation oncologists, oncology nurses, and other allied health professionals.
Type of Activity: Knowledge
Release date: April 30, 2015
Expiration date: April 30, 2016
Estimated time to complete activity: 2 hours

To view this CME activity, click here >>>

Featuring Consultations With
Joyce O'Shaughnessy, MD
Chair, Breast Cancer Research
Baylor-Sammons Cancer Center
Texas Oncology, US Oncology
Dallas, TX

Linda T. Vahdat, MD
Professor of Medicine
Director of the Breast Cancer Research Program,
Chief of the Solid Tumor Service
Weill Cornell Medical College
New York, NY

With Community Oncologist's Perspective by
Hussein Ali-Ahmad, MD
Clinical Assistant Professor of Oncology
Roswell Park Cancer Institute
Jamestown, NY

Editorial Support

Sigrid Eckhardt
Hitt Medical Writing, LLC

This activity is supported by an educational grant from Eisai.

To view this CME activity, click here >>>

Publications
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.